A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
08/2011
08/30/2011	US8008077 Photochemical internalization for delivery of molecules into the cytosol
08/30/2011	US8007830 Oral granules of montelukast sodium; e.g. spray-dried mannitol coated with said drug; may be ingested directly or mixed with food or other comestibles for patients who have difficulty swallowing
08/30/2011	US8007817 Compositions and methods for treating microbial infections
08/30/2011	US8007815 Combination meningitidis B/C vaccines
08/30/2011	US8007798 Treatment of complement-associated disorders
08/30/2011	US8007781 Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
08/30/2011	US8007777 Controlled release system composition for administration of a biological component, preferably, a probiotic bacterium
08/30/2011	US8007767 Amino methyl imidazoles and related compounds as C5a receptor modulators
08/30/2011	CA2542813C Amidomethyl-substituted 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2h-chromen-6-yl-derivatives, process and drugs containing these compounds
08/30/2011	CA2440473C Metalloproteinase inhibitors
08/30/2011	CA2438717C 6-phenylbenzonaphthyridines
08/30/2011	CA2406392C Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
08/30/2011	CA2393352C Adamantane derivatives
08/30/2011	CA2372150C Therapeutic applications of pro-apoptotic benzodiazepines
08/25/2011	WO2011103524A2 Cyclic tetrapeptides and therapeutic applications thereof
08/25/2011	WO2011103423A1 Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors
08/25/2011	WO2011102668A2 Colchicine derivatives or pharmaceutically acceptable salts thereof, method for preparing said derivatives, and pharmaceutical composition comprising said derivatives
08/25/2011	WO2011102529A1 Epithelial cell-cell adhesion enhancer, and ameliorating, therapeutic or prophylactic agent for allergic diseases using same
08/25/2011	WO2011102404A1 Imidazole derivative
08/25/2011	WO2011102149A1 Use of ep4 receptor antagonists in the treatment of il-23 mediated diseases
08/25/2011	WO2011102035A1 Prophylactic/ameliorating agent for diseases, endurance improving agent and anti-fatigue agent, and pharmaceutical agent, food and beverage each comprising any one of those agents
08/25/2011	WO2011101870A1 Fusion proteins for the treatment of multiple sclerosis and other autoimmune diseases
08/25/2011	WO2011101806A1 Bicyclic compounds and their uses as dual c-src / jak inhibitors
08/25/2011	WO2011100786A1 Compositions and methods for targeting type 1 interferon producing cells
08/25/2011	WO2011075822A8 Immunogenic compositions and related methods
08/25/2011	WO2011055215A3 Novel benzopyran kinase modulators
08/25/2011	WO2011052996A3 Novel lactobacillus plantarum and composition comprising the same
08/25/2011	WO2011047384A9 Methods of inhibiting ire1
08/25/2011	WO2011004282A3 Novel polymorphic form of teriflunomide salts
08/25/2011	US20110209248 Novel sugar transporters
08/25/2011	US20110208673 Antibodies to lymphotoxin-alpha
08/25/2011	US20110207807 New use for homoisoflavone or a salt thereof
08/25/2011	US20110207801 Novel Genes, Compositions, and Methods for Modulating the Unfolded Protein Response
08/25/2011	US20110207765 Topical composition comprising a combination of at least two penetration enhancing agents
08/25/2011	US20110207763 8-carboxamido-2,6-methano-3-benzazocines
08/25/2011	US20110207754 Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors
08/25/2011	US20110207746 New compounds i
08/25/2011	US20110207734 Azine Derivatives and Methods of Use Thereof
08/25/2011	US20110207730 Ion channel modulating compounds and uses thereof
08/25/2011	US20110207725 CHIRAL FUSED [1,2]IMIDAZO[4,5-c] RING COMPOUNDS
08/25/2011	US20110207713 PYRIDO[3,2-d]PYRIMIDINE PI3K DELTA INHIBITOR COMPOUNDS AND METHODS OF USE
08/25/2011	US20110207224 In vivo production of small interfering rnas that mediate gene silencing
08/25/2011	US20110207211 Expression of immunoglobulin-cytokine fusion proteins in malignant b cells
08/25/2011	US20110206786 Acai and Iridoid Based Formulations
08/25/2011	US20110206765 Non-Typeable Haemophilus Influenzae Vaccines and Their Uses
08/25/2011	US20110206760 Angiopoietin derived peptides
08/25/2011	US20110206759 Ccr7 ligand delivery and co-delivery in immunotherapy
08/25/2011	US20110206758 Vaccine Compositions Comprising a Saponin Adjuvant
08/25/2011	US20110206755 Methods and products for manipulating uncoupling protein expression
08/25/2011	US20110206740 Cell Membrane Engineering
08/25/2011	US20110206733 Immunizing Compositions and Methods of Use
08/25/2011	US20110206730 Dengue Chimeric Viruses
08/25/2011	US20110206729 Mucosal vaccine using cationic nanogel
08/25/2011	US20110206728 Dna vaccines, uses for unprocessed rolling circle amplification product and methods for making the same
08/25/2011	US20110206727 Multivalent Vaccines Based on Papaya Mosaic Virus and Uses Thereof
08/25/2011	US20110206726 Combination vaccine with acellular pertussis
08/25/2011	US20110206725 Method for purifying protein complexes
08/25/2011	US20110206724 Hepatitis virus core proteins as vaccine platforms and methods of use thereof
08/25/2011	US20110206721 Fermented soy nutritional supplements including mushroom components
08/25/2011	US20110206719 Immunostimulatory oligoribonucleotides
08/25/2011	US20110206717 Non-typhoidal salmonella vaccines
08/25/2011	US20110206716 Synergistic immunogenic fusion protein-polysaccharide conjugate
08/25/2011	US20110206715 Molecular differences between species of the m. tuberculosis complex
08/25/2011	US20110206712 Tuberculosis rv2386c protein, compositions and uses thereof
08/25/2011	US20110206709 T-cell antigen peptide from allergen for stimulation of il-10 production
08/25/2011	US20110206708 Method for stimulating a therapeutic immune effect in a patient
08/25/2011	US20110206707 Method for stimulating a host immune system
08/25/2011	US20110206699 Methods for the Treatment of Graft-Versus-Host Disease
08/25/2011	US20110206698 Antagonist anti-il-7 receptor antibodies and methods
08/25/2011	US20110206686 Il-23 antibodies
08/25/2011	US20110206684 Method of producing nutritional products from human milk tissue and compositions thereof
08/25/2011	US20110206676 Compositions and methods related to staphylococcal bacterium proteins
08/25/2011	US20110206672 Antigen-Binding Molecule And Uses Thereof
08/25/2011	US20110206669 Mcp1 fusions
08/25/2011	US20110206668 Methods and compositions for modulating immunity
08/25/2011	US20110206663 Anti-Interferon-Alpha Antibodies
08/25/2011	US20110206660 Amino acid sequences directed against cxcr4 and other gpcrs and compounds comprising the same
08/25/2011	US20110206659 Methods and treatment for allergies and inflammation associated with gastrointestinal diseases
08/25/2011	US20110206610 Compositions and methods for enhancing drug delivery across and into epithelial tissues
08/25/2011	DE102010008982A1 Siliciumhaltiges, biologisch degradierbares Material zur anti-inflammatorischen Therapie A silicon-containing biologically degradable material for anti-inflammatory therapy
08/25/2011	DE102010008981A1 Siliciumhaltiges, biologisch degradierbares Material zur pro-angiogenetischen Therapie A silicon-containing biologically degradable material for pro-angiogenic therapy
08/25/2011	CA2827694A1 Cyclic tetrapeptides and therapeutic applications thereof
08/25/2011	CA2790783A1 Epithelial cell-cell adhesion enhancer, and ameliorating, therapeutic or prophylactic agent for allergic diseases using same
08/25/2011	CA2790070A1 Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors
08/25/2011	CA2789810A1 Compositions and methods for targeting type 1 interferon producing cells
08/25/2011	CA2789665A1 Use of ep4 receptor antagonists in the treatment of il-23 mediated diseases
08/25/2011	CA2789655A1 Bicyclic compounds and their uses as dual c-src / jak inhibitors
08/24/2011	EP2360260A1 BASB006 polynucleotide(s) and polypeptides from Neisseria meningitis
08/24/2011	EP2360254A1 Assays for screening anti-pd-1 antibodies and uses thereof
08/24/2011	EP2360253A1 RNA sequence-specific mediators of RNA interference
08/24/2011	EP2360252A1 Immunostimulatory nucleic acid molecules comprising GTCGTT motifs
08/24/2011	EP2360251A2 In vivo production of small interfering RNAs that mediate gene silencing
08/24/2011	EP2360185A2 Administration of agents for the treatment of inflammation
08/24/2011	EP2360184A2 Antibodies that bind human interleukin-18 and methods of making and using
08/24/2011	EP2360169A2 PSMA antibodies
08/24/2011	EP2359855A2 Methods of administering anti-TNFalpha antibodies
08/24/2011	EP2359850A1 Single-time vaccines
08/24/2011	EP2359849A1 Combination therapy
08/24/2011	EP2359831A2 Therapeutic applications of pro-apoptotic benzodiazepines
08/24/2011	EP2359821A1 Dosage regimen of an s1p receptor agonist

1 ... 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 ... 1172